Clinical research plays a fundamental role in the advancement of cancer treatment and, among the main sources of funding for these studies, are supporting companies. The Cura Project Institute highlights the importance of these companies for clinical oncology research, such as those developed by LACOG - Latin American Cooperative Oncology Group.

Cancer is one of the leading causes of morbidity and mortality worldwide, requiring continuous efforts to develop new therapies and treatments. According to Dr. Carlos Barrios, Oncologist and President of LACOG:

“Latin America has more than 600 million people and 1 million new cases of cancer each year. Clinical research is an opportunity for cancer patients, yet only 7.5% of cancer clinical trials are open in the region.”

LACOG, as a leading cooperative group in Latin America dedicated to clinical research in oncology, with an emphasis on the development of innovative therapies, is currently conducting 12 clinical studies and 24 epidemiological studies.

The NEOSAMBA study stands out, a study that evaluates the sequencing of neoadjuvant chemotherapy in patients with breast cancer. This study will include nearly 500 patients and will help define the best treatment strategy for patients with breast cancer. In this context, the Cura Project Institute, LACOG and GBECAM, are proud to thank the support of companies that play a crucial role in the advancement of clinical oncology research. They are: Arteris, Cristália, Crown Embalagens, Elo, Nutrien Agricultural Solutions, PRIO, Rede D`Or and XP.

About the Cura Project Institute
The Cura Project Institute, a non-profit entity, promotes scientific, educational and social activities to increase civil society's awareness of the benefits of clinical research and to raise funds to finance independent studies to combat cancer in Brazil. More information can be found on the official website of the Cura Project Institute and on its social networks Instagram, Facebook and LinkedIn

About LACOG
LACOG — The Latin American Cooperative Oncology Group — is a non-profit organization founded in 2009 by a group of Latin American medical oncologists interested in developing clinical research. This is the first multinational cooperative group in Latin America dedicated to clinical and epidemiological cancer research. LACOG currently has more than 507 member researchers present at 200 institutions in 16 Latin American countries. The group develops observational studies to describe the diagnosis, treatment, and survival of cancer patients in various types of tumors, and also conducts clinical trials investigating new
biomarkers and new drugs.

About GBECAM
GBECAM is an independent, non-profit organization whose main objective is to develop, implement, and facilitate the conduct of multi-institutional clinical studies of scientific and ethical quality on breast cancer in Brazil, as well as to implement and assist educational programs for the clarification and prevention of breast cancer.